Showing 61 - 80 results of 132 for search '(( significantly ((larger decrease) OR (we decrease)) ) OR ( significantly associated disease ))~', query time: 0.47s Refine Results
  1. 61

    Image 4_Assessment of heart rate deceleration capacity, heart rate deceleration runs, heart rate acceleration capacity, and lipoprotein-related phospholipase A2 as predictors in in... by Yaping Wang (289641)

    Published 2025
    “…Background<p>Autonomic dysfunction plays an essential role in dementia, however, it is not known whether electrocardiogram autonomic dysfunction-related indicators are associated with the severity of dementia. In this study, we attempted to investigate whether these indicators are correlated in patients with vascular dementia and Alzheimer’s disease compared with normal health individuals. …”
  2. 62

    Image 3_Assessment of heart rate deceleration capacity, heart rate deceleration runs, heart rate acceleration capacity, and lipoprotein-related phospholipase A2 as predictors in in... by Yaping Wang (289641)

    Published 2025
    “…Background<p>Autonomic dysfunction plays an essential role in dementia, however, it is not known whether electrocardiogram autonomic dysfunction-related indicators are associated with the severity of dementia. In this study, we attempted to investigate whether these indicators are correlated in patients with vascular dementia and Alzheimer’s disease compared with normal health individuals. …”
  3. 63

    Image 1_Assessment of heart rate deceleration capacity, heart rate deceleration runs, heart rate acceleration capacity, and lipoprotein-related phospholipase A2 as predictors in in... by Yaping Wang (289641)

    Published 2025
    “…Background<p>Autonomic dysfunction plays an essential role in dementia, however, it is not known whether electrocardiogram autonomic dysfunction-related indicators are associated with the severity of dementia. In this study, we attempted to investigate whether these indicators are correlated in patients with vascular dementia and Alzheimer’s disease compared with normal health individuals. …”
  4. 64

    Table_1_A two-years real-word study with fingolimod: early predictors of efficacy and an association between EBNA-1 IgG titers and multiple sclerosis progression.xlsx by Maria Inmaculada Dominguez-Mozo (18781135)

    Published 2024
    “…Regarding the possible contribution of the environmental factors included in the study to the activity or the progression of the disease, we only found that EBNA-1 IgG titers decreased in 20.0% of PIRA (progression independent from relapse activity) patients vs. 73.3% of RAW (relapse-associated worsening) patients (p=0.006; O.R. = 11.0).…”
  5. 65

    Characterization of air flow and lung function in the pulmonary acinus by fluid-structure interaction in idiopathic interstitial pneumonias by Long Chen (315739)

    Published 2019
    “…</p><p>Findings</p><p>In a normal breathing cycle, the flow rate of the healthy model is significantly larger than that of the NSIP and IPF models. …”
  6. 66
  7. 67
  8. 68
  9. 69
  10. 70
  11. 71

    fairness_bias.pdf by fuchen li (18348535)

    Published 2024
    “…Model bias and fairness were</em></p> <p><em>evaluated using equal opportunity difference (EOD, 0 indicates fairness) and disparate impact (DI, 1 indicates</em></p> <p><em>fairness). In our study, we also evaluated the fairness of a non-ML baseline model, the American Heart Association</em></p> <p><em>(AHA) Pooled Cohort Risk Equations (PCEs). …”
  12. 72

    fairness_ML_CVD_2023.pdf by Fuchen Li (18334895)

    Published 2024
    “…For debiasing methods, removing protected attributes didn’t significantly reduced the bias for most ML models. Resampling by sample size also didn’t consistently decrease bias. …”
  13. 73
  14. 74

    Abnormal preoperative haematological parameters in Endometrial cancer; reflecting tumour aggressiveness or reduced response to radiotherapy? by Stephanie W. Vrede (17751147)

    Published 2024
    “…In patients that were treated with adjuvant radiotherapy (<i>n</i> = 239), anaemia was associated with significant reduced 5-year disease-specific and recurrence-free survival (<i>P</i> = 0.005 and <i>P</i> = 0.025, respectively). …”
  15. 75
  16. 76
  17. 77
  18. 78
  19. 79
  20. 80

    Pam2CSK4 (TLR2 agonist) induces periodontal destruction in mice by João Antonio Chaves de SOUZA (8438055)

    Published 2020
    “…Importantly, treatment not only with LPS but also with PAM2 resulted in a larger number of TRAP+ multinucleated osteoclasts and significant loss of alveolar bone. …”